A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting

NCT07709897 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Postoperative Nausea and Vomiting

Interventions

DRUG: HRS5580 for injection combined with palonosetron hydrochloride;
DRUG: HRS5580 for injection combined with palonosetron hydrochloride
DRUG: HRS5580 for injection blank preparation combined with palonosetron hydrochloride

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.